These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Black pigmented aortic valve and sinus of Valsalva caused by life-long minocycline therapy. Tsunekawa T; Jones KW; Doty JR Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):339-40. PubMed ID: 24824497 [TBL] [Abstract][Full Text] [Related]
43. The uptake and release of antibiotics by lyophilized bone. Egyedi P; Guggenheim B J Maxillofac Surg; 1973 Sep; 1(3):177-82. PubMed ID: 4520656 [No Abstract] [Full Text] [Related]
44. The in vivo distribution of tetracyclines in canine bone. HARRIS WH; JACKSON RH; JOWSEY J J Bone Joint Surg Am; 1962 Oct; 44-A():1308-20. PubMed ID: 19777627 [TBL] [Abstract][Full Text] [Related]
45. Bone localization of the tetracyclines. MILCH RA; RALL DP; TOBIE JE J Natl Cancer Inst; 1957 Jul; 19(1):87-93. PubMed ID: 13502708 [No Abstract] [Full Text] [Related]
46. [TETRACYCLINE IN BONES AND TEETH]. KIENITZ M Dtsch Med Wochenschr; 1965 Jul; 90():1298-302. PubMed ID: 14315003 [No Abstract] [Full Text] [Related]
47. Fluorometric determination of demethylchlortetracycline and tetracycline in mammalian bone. Hawkins KI Anal Biochem; 1972 Jan; 45(1):128-36. PubMed ID: 4333122 [No Abstract] [Full Text] [Related]
48. Relationships of static and kinetic histomorphometric features of bone. Teitelbaum SL; Bates M Clin Orthop Relat Res; 1980; (146):239-45. PubMed ID: 6989538 [TBL] [Abstract][Full Text] [Related]
49. [TETRACYCLINE AND BONE METABOLISM]. KAEMMERER H; EGER W Med Welt; 1965 May; 18():986-91. PubMed ID: 14291131 [No Abstract] [Full Text] [Related]
50. Black Bone Disease of the Foot: A Two-Year Follow-Up Case Study. Cornejo A; Kerbleski GJ J Foot Ankle Surg; 2018; 57(6):1259-1262. PubMed ID: 30001940 [TBL] [Abstract][Full Text] [Related]
51. Bone growth kinetics. I. Modifications of the tetracycline labelling technique. Tam CS; Reed R; Cruickshank B J Pathol; 1974 May; 113(1):27-38. PubMed ID: 4606279 [No Abstract] [Full Text] [Related]
52. Tetracyclines, doxycycline and calcified tissues. Dhem A; Piret N; Fortunati D Scand J Infect Dis Suppl; 1976; (9):42-6. PubMed ID: 1070147 [TBL] [Abstract][Full Text] [Related]
53. [ON THE ADMINISTRATION OF ANTIBIOTICS IN THE PERINATA PERIOD]. JANOVSKY M Cesk Pediatr; 1964 Jan; 19():65-6. PubMed ID: 14133308 [No Abstract] [Full Text] [Related]
54. DISCOLURATION OF TEETH ASSOCIATED WITH INTENSIVE TETRACYCLINE THERAPY IN INFANCY. ZEGARELLI EV; KUTSCHER AH; FAHN B N Y State J Med; 1963 Sep; 63():2703-4. PubMed ID: 14054542 [No Abstract] [Full Text] [Related]
56. Binding of tetracyclines to bone. Perrin DD Nature; 1965 Nov; 208(5012):787-8. PubMed ID: 5868891 [No Abstract] [Full Text] [Related]
57. Yellow lunulae with fluorescence after tetracycline therapy. Hendricks AA Arch Dermatol; 1980 Apr; 116(4):438-40. PubMed ID: 6445177 [TBL] [Abstract][Full Text] [Related]
58. [On the problem of pigment metabolism disorders in syringomyelia]. KAMIANOV IM Zh Nevropatol Psikhiatr Im S S Korsakova; 1962; 62():703-5. PubMed ID: 14453438 [No Abstract] [Full Text] [Related]
59. Minocycline-induced pigmentation. Incidence, prevention and management. Eisen D; Hakim MD Drug Saf; 1998 Jun; 18(6):431-40. PubMed ID: 9638388 [TBL] [Abstract][Full Text] [Related]
60. Minocycline-induced intraoral pharmacogenic pigmentation: case reports and review of the literature. Westbury LW; Najera A J Periodontol; 1997 Jan; 68(1):84-91. PubMed ID: 9029456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]